Cylate
Cylate Brand names, Cylate Analogs
Cylate Brand Names Mixture
- No information avaliable
Cylate Chemical_Formula
C17H25NO3
Cylate RX_link
No information avaliable
Cylate fda sheet
Cylate msds (material safety sheet)
Cylate Synthesis Reference
No information avaliable
Cylate Molecular Weight
291.385 g/mol
Cylate Melting Point
139 oC (hydrochloride salt)
Cylate H2O Solubility
No information avaliable
Cylate State
Solid
Cylate LogP
3.124
Cylate Dosage Forms
Ophthalmic solution (eye drops)
Cylate Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Cylate Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Cylate Absorption
Absorbed following ophthalmic administration.
Cylate side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Cylate Patient Information
No information avaliable
Cylate Organisms Affected
Humans and other mammals
